♫musicjinni

Longitudinal Study of GI Treatment in Autism ASD - Arthur Krigsman, MD @Synchrony2020

video thumbnail
Arthur Krigsman, MD is a pediatrician and pediatric gastroenterologist with expertise in the evaluation and treatment of autism associated gastrointestinal problems. His interest in this unique patient population began in 2001 and during the ensuing 17 years he has treated over 1900 children from across the globe suffering from autism and a variety of gastrointestinal problems.

His research interest lies in the characterization of the unique cellular, molecular, and clinical features of ASD-associated inflammatory bowel disease and his original findings appear in numerous peer-reviewed journals.

In addition to serving as an invited reviewer for peer-reviewed medical journal author submissions in his area of expertise, Dr. Krigsman has served as a guest lecturer on the topic of gastrointestinal disease and autism at national and international scientific meetings, hospital Grand Rounds both here and abroad, Nurse Association meetings, philanthropic organizations, and at numerous lay medical conferences. He has also presented his findings before the U.S. Congress. His greatest satisfaction though derives from the clinical care he provides his patients and in the improved quality of life that results from diagnosing and treating gastrointestinal disease in this vulnerable population.

He maintains offices in both New York City and Austin, Texas.


This talk was part of Synchrony 2020 Online Symposium - 'From Bench to Biopharma', organised by the The BRAIN Foundation in partnership with UC Davis MIND Institute and CalTech.

For more Synchrony 2020 talks and highlights: https://www.youtube.com/playlist?list=PLDtO9h17tcWcRGZHOgtNG9YMJ7BJkO6VR

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder.

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care.

To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.

Longitudinal Study of GI Treatment in Autism ASD - Arthur Krigsman, MD @Synchrony2020

Panel Discussion: New Autism Spectrum Disorder ASD Therapeutics in Development @Synchrony 2020

Watch Synchrony 2023 Recordings & Earn CME Credits with The Pathways - ASD Translational Research

Biometric-Guided TMS for Kleefstra Syndrome and ASD - Erik Won, Wave Neuro @Synchrony2021

Synchrony 2023 Talk TRAILER: EEG Past, Present & Future - Implications for Autism, John Gaitanis MD

Synchrony 2023 talk TRAILER: Transcranial Photobiomodulation for Autism - Luis De Taboada

Synchrony 2020 HIGHLIGHTS: 'From Genes to Novel Therapeutics in Autism' - Joseph Buxbaum PhD

From Rare Mutations to Common Treatments in Autism - M. Lalli PhD, Icahn School of Med. @Synchrony22

Research and Innovation in ASD - Session Chair Remarks – John Rodakis MBA @Synchrony2020

Synchrony 2023 talk TRAILER: Microbiota Transplant Therapy for Autism, J.Adams & K.Nirmalkar PhD

Save the Date: Translational Research in Autism - Synchrony Symposium - July 12-14, Asilomar CA

Synchrony 2023 talk TRAILER: Modeling Autism with Human Brain Organoids - Alysson Muotri PhD

Developing Autism Therapeutic Agents - Kevin Sanders MD, Roche/Genentech @Synchrony2020

Synchrony 2023 Talk TRAILER: Testing New Interventions in Autism - Jeremy Veenstra-VanderWeele MD

Safety, Tolerability & Efficacy of AB-2004 in ASD - S Campbell PhD, Axial Therapeutcs @Synchrony2020

Richard Frye, MD, PhD- Synchrony 2019

Assessments in ASD Clinical Trials during COVID - Lisa Nowinski PhD, Harvard @Synchrony2020

Novel Therapeutics for Neurobehavioral Aspects of ASD – S Lipton, MD PhD, Scripps @Synchrony2020

Update on Mitochondrial Research in Autism - Richard Frye, MD @Synchrony 2021

Opportunities for the Advancement of ASD – Diane Stephenson PhD, C-Path Institute @Synchrony2020

Enabling Precision Medicine Drug Development for ASD - Stalicla @Synchrony2020

James Adams, PhD & Rosa Krajmalnik Brown, PhD- Synchrony 2019

Understanding & Treating Autism: Neuroarcheology Concept - Y Ben Ari PhD, Neurochlore @Synchrony2020

Measurement of Restricted and Repetitive Behaviors in ASD – Julian Tillman PhD, Roche @Synchrony2020

Neuromodulation as Component of Treatment Program for ASD – K Shapiro MD PhD, Cortica @Synchrony2020

Synthesizing the ASD Microbiome Field - Robert Mills @Synchrony2022

Synchrony 2023 Talk TRAILER: Using Vagus Nerve Stimulation Therapy for Autism - Crystal Engineer PhD

Glimpses of Synchrony 2019

Synchrony 2023 Talk TRAILER: From 'Chasing My Cure' to Every Cure Repurposing Existing Drugs for ASD

Edward Quadros, PhD- Synchrony 2019

Disclaimer DMCA